Winston-Salem, NC (PRWEB) August 13, 2014
PMG Research, Inc. announced today its designation as a Quintiles Prime Site. PMG Research provides clinical research services to large physician practices and integrated health systems, with access to 1.7 million patient lives. PMG Research is comprised of 10 hub site locations and spans 53 physician practices. PMG Research and Quintiles have been working together for 20 years to deliver clinical research solutions to the pharmaceutical industry.
The mission of PMG Research is to bring clinical research to as many lives as possible while delivering unparalleled service and exceptional value to its clinical trial partners and stakeholders. PMG Research, celebrating its 35th anniversary this year, has conducted over 7,100 trials for hundreds of pharmaceutical sponsors and CROs and has extensive experience conducting all phases of clinical research across a comprehensive list of conditions.
“We are incredibly proud to have been selected as a Quintiles Prime Site,” explains Jennifer Byrne, CEO of PMG Research. “Our broad therapeutic capabilities, strong regulatory track record, deeply engaged physician investigators, and continuously growing access to patients makes PMG Research a great fit for the Prime Site program. We look forward to taking what is already a highly collaborative relationship to the next level, building a transformational partnership that allows us to better achieve our mission: bringing clinical research to as many lives as possible.”
“The healthcare landscape is changing, and advances in science, analytics and therapeutic knowledge offer the promise of better treatments. The realization of this promise will only be possible by working differently, and our Prime Site program is an example of this,” explains Lindy Jones, Head of Integrated Patient & Site Strategies, Quintiles. "We are proud to be working with the team at PMG Research with whom we already have a track record of success having worked together on over 300 studies which have enrolled over 3200 patients. With the enthusiasm and vision for this model that our PMG Research Care partner has shown, we are confident that this will serve as a strong foundation for future collaboration as we strive to improve our customers’ probability of success.”
About PMG Research, Inc.
PMG Research, Inc. is an integrated network of clinical research facilities with hub sites located in Cary, Charlotte, Hickory, Raleigh, Salisbury, Wilmington, and Winston-Salem, NC; Charleston, SC; and Bristol and Knoxville, TN. PMG has conducted 7,100 research studies for hundreds of pharmaceutical sponsors and CROs since 1979. We have extensive experience conducting all phases of trials across a comprehensive list of conditions. Our mission is to bring clinical research to as many lives as possible while delivering unparalleled service and exceptional value to our clinical trial partners and stakeholders. To learn more, visit http://www.pmg-research.com.
Quintiles is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 30,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit http://www.quintiles.com.
Read the full story at http://www.prweb.com/releases/2014/08/prweb12090609.htm.
Copyright©2014 Vocus, Inc.
All rights reserved